iBio, Inc. is a biotech company. The Company develops next-generation biopharmaceuticals for cardiometabolic, obesity, cancer and other hard-to-treat diseases through AI and advanced computational biology. iBio…

News, deals & research about iBio

Latest in AI

Nothing tagged yet, items mentioning iBio will appear here as the desk publishes them.

Prices are daily closes from the Lounge market update; not investment advice.

Company

ibioinc.com ↗

HQSan Diego, California, USA

ExchangeNASDAQ

SectorBiotechnology

In AI IndexNo

As of2026-10-06

Company

ibioinc.com ↗

HQSan Diego, California, USA

ExchangeNASDAQ

SectorBiotechnology

In AI IndexNo

As of2026-10-06

Home Directory Events News Chat

ARR Leaderboard

Venture Rounds

DeepSeekGrowth · Oct 6$11.9B

VinciSeries B · Oct 6$250M TTeddy AISeed · Oct 6$60M

HadrianGrowth · Oct 6$40M

Exits

Open →

TechWolfAcquired · Oct 6—

LambdaIPO · Oct 6$4B

PTCAcquired · Oct 5$22.6B

PPG Digital & LeadCoverageAcquired · Oct 5$20M

ARR Leaderboard

Venture Rounds

DeepSeekGrowth · Oct 6$11.9B

VinciSeries B · Oct 6$250M TTeddy AISeed · Oct 6$60M

HadrianGrowth · Oct 6$40M

Exits

Open →

TechWolfAcquired · Oct 6—

LambdaIPO · Oct 6$4B

PTCAcquired · Oct 5$22.6B

PPG Digital & LeadCoverageAcquired · Oct 5$20M

Paid members see AI Stocks and the Lounge AI Index, prices, market caps, P/E and returns for the whole public AI trade, plus CSV exports. Developer membership is $9/mo.

See plans →Log in